Neuberger Berman Group
RXDX

Neuberger Berman Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Neuberger Berman Group’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,228
Closed -$883K – 1899
2023
Q1 		$883K Buy
8,228
+409
+5% +$43.9K ﹤0.01% 1291
2022
Q4 		$860K Buy
+7,819
New +$860K ﹤0.01% 1277